在您下載用藥資訊前可以先閱讀「癌症用藥知識您不可不知」
癌症藥物(專業版)
所有分類
- ALK TKI
- Angiogenesis
- BcrABL TKI
- BRAF inhibitors
- BTK inhibitors TKI
- CDK inhibitors
- Conjugated antibody
- EGFR TKI
- FGFR inhibitors TKI
- Her2 inhibitors TKI
- KRAS inhibitors TKI
- MEK inhibitors TKI
- Monoclonal antibody
- mTOR inhibitors
- Multikinase inhibitors
- NTRK inhibitors TKI
- PARP inhibitors
- Phosphoinositide 3-kinase inhibitors
- Proteasome inhibitors
- Immune modulator
- BCL-2 inhibitor
- FLT3 inhibitors
- JAK inhibitors
- IL6 inhibitors
- Bispecific Antibody
- RET inhibitors TKI
- MET inhibitor
- AKT inhibitor
- IDH1 Inhibitors
- IDH2 inhibitor
Trametinib (Mekinist ® Tablet ) 麥欣霓膜衣錠專業版
細胞中許多重要蛋白質和細胞生長訊息傳遞有關，某些癌細胞增生與BRAF-MEK-ERK路徑過度活化有關，MEK inhibitor搭配BRAF inhibitor就此開始發展。此藥最早使用於黑色素瘤，從轉移性慢慢推展到輔助性療法皆有看到長期的存活率。陸續在非小細胞肺癌及甲狀腺未分化癌也看到效果。